Toni K. Choueiri, Sumanta Kumar Pal, Rana R. McKay, Cristina Suarez, John Haanen, Deepti Warad, Christopher Negro, Melissa Jeanne Eisen, Paul G. Foster, Thomas Powles. "PEAK-1: A randomized, double-blind, active-control, multicenter phase 3 trial of casdatifan and cabozantinib versus placebo and cabozantinib in patients with advanced clear cell renal cell carcinoma.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps4636